Montvale, NJ- April 11, 2017 – EmpiRx Health is pleased to announce that Kristin Begley, PharmD, Chief Revenue Officer, will be speaking at the Goldman Sachs Drug Pricing Shakeout Conference on April 13th.
“I am honored to be speaking at the Goldman Sachs Drug Pricing Shakeout Conference. EmpiRx Health believes we are the next generation PBM (we think of ourselves as a Pharmacy Care Manager) deploying a model that ensures complete payer and member alignment with accountability and risk for our performance” said Kristin Begley, Chief Revenue Officer.”
The conference, which will take place at the Goldman Sachs Conference Center, located at 200 West Street in New York City, from 9:00-1:30, will feature panel sessions moderated by Goldman Sachs analysts with key stakeholders in the debate. Experts from the Biopharma, PBM and Healthcare policy areas will be speaking on the growing out of pocket costs for consumers and the political landscape. Potential evolution of the drug pricing model in the U.S. and implications for the healthcare industry remain a focus.
About EmpiRx Health
EmpiRx Health is a full-service revolutionary pharmacy benefits management company founded by industry thought leaders in 2014. Their focus is simple: provide concierge service and proactive oversight to eliminate inefficiencies, maximize annual savings and preserve benefit dollars for today’s high-cost pharmacy benefits market. Headquartered in Montvale, NJ, EmpiRx Health uses their signature Pharmacy Care Management model to effectively manage gaps in service and provide superior clinical and financial solutions in an empirical manner. EmpiRx Health partners consultatively with brokers, consultants, third party administrators, employers and unions providing actionable information, customized reporting and advance technology tools to achieve lower overall pharmacy costs.
SOURCE EmpiRx Health LLC